Eyepoint Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Eyepoint Inc's ROI in the second quarter of 2026?
Eyepoint Inc recorded a cumulative net loss of $-307 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -124.45%.

Within the Healthcare sector 636 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3823 to 4023.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	-15.93 %	-6.73 %	4.78 %	14.03 %	33.02 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	186	251	327	222	268
Return On Investment (TTM)	-124.45 %	-101.79 %	-81.57 %	-70.72 %	-59.84 %
EYPT's Overall Ranking	# 4023	# 3823	# 2733	# 3320	# 3109
Seq. Investment Change TTM	-7.66 %	-6.17 %	-2.26 %	-0.73 %	2.45 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-307	-272	-232	-206	-175

EYPT Company Profile >> Back to EYPT Roi Comparisons >> See Annual EYPT Return On Investment

Return On Investment EYPT's Ranking
Within:	No.
Industry	# 23
Sector	# 637
Overall	# 4023

Return On Investment Statistics
High	Average	Low
51.78 %	-75.31 %	-203.76 %
(Sep 30 2014)		(Dec 31 2017)

Financial Statements
Eyepoint Inc's II. Quarter Investments	$ 186 Millions	EYPT's Balance sheet
Eyepoint Inc's II. Quarter Income	$ -94 Millions	Quarterly EYPT's Income Statement
EYPT's Income by Division		See EYPT's Income by Division

EYPT Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	312	353	288	141	244
Y / Y Investment Growth	-11.78 %	22.51 %	103.82 %	-42.12 %	200.66 %
Net Income in Millions	-232	-131	-71	-102	-58
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-74.42 %	-37.04 %	-24.55 %	-72.27 %	-23.9 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Laboratory Analytical Instruments Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
EYPT's Roi Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for EYPT's Competitors
Subscribers only: Roi for Eyepoint Inc's Suppliers
Subscribers only: Return On Investment for EYPT's Customers

Other Ratios
EYPT's Roa	EYPT's Inventory Turnover Ratio	EYPT's Growth Rates	EYPT's Dividend Statistics
	EYPT's Profitability Ratios	EYPT's Asset Turnover Ratio	EYPT's Dividend Growth
EYPT's Roe	EYPT's Valuation Ratios	EYPT's Financial Strength Ratios	EYPT's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-10T13:21:22+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.